Business Standard

Ganga Pharmaceuticals Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Statement Of Deviation For March 31 2024 Statement of Deviation or Variation for March 31 202416/05/2024
Board Meeting Outcome for Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31 2024. Audited Financial Results of the Company for the half and financial year ended o...Read More16/05/2024
Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31 2024. Audited Financial Results of the Company for the half and Financial year ended ...Read More16/05/2024
Board Meeting Intimation for To Inter Alia Consider And Approve The Audited Financial Results Of The Company For The Half And Financial Year Ended March 31 2024. Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Direc...Read More06/05/2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A <b>Format of Initial Disclosure to be made by an entity identified as a Large Co...Read More25/04/2024
Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation 2015 For The Year Ended On March 31 2024 Submission of Certificate under clause 40(10) of SEBI (LODR) Regulation 2015 for...Read More11/04/2024
Compliance Certificate Issued Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2024 Please find attached herewith the Certificate under Regulation 7(3) of SEBI (LOD...Read More06/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg. 74(5) of the SEBI (DP) Regulation 2018 for the...Read More06/04/2024
Closure of Trading Window Intimation for Trading Window Closure28/03/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More07/02/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More07/02/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More07/02/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More07/02/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More27/01/2024
Announcement under Regulation 30 (LODR)-Allotment Intimation under Regulation 30 of SEBI(Listing Obligation and Disclosure Require...Read More19/01/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74 (5) of the SEBI (DP) Regulations 2018 for the qu...Read More10/01/2024
Shareholder Meeting / Postal Ballot-Scrutinizers Report Voting Result of the EGM of Ganga Pharmaceuticals Limited held on Thursday Janua...Read More04/01/2024
Shareholder Meeting / Postal Ballot-Outcome of EGM Proceedings of Extra-Ordinary General Meeting (EGM) of Ganga Pharmaceuticals Lim...Read More04/01/2024
Closure of Trading Window Intimation for Trading Window Closure27/11/2023
Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Direc...Read More27/11/2023

Load more